Ralph Mosley

1.8k total citations
15 papers, 1.2k citations indexed

About

Ralph Mosley is a scholar working on Molecular Biology, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Ralph Mosley has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Physiology and 2 papers in Endocrine and Autonomic Systems. Recurrent topics in Ralph Mosley's work include Receptor Mechanisms and Signaling (7 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Adipose Tissue and Metabolism (4 papers). Ralph Mosley is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Adipose Tissue and Metabolism (4 papers). Ralph Mosley collaborates with scholars based in United States. Ralph Mosley's co-authors include Alexander C. Ferguson, Joseph L. Evans, Joel P. Berger, David E. Moller, Susan P. Rohrer, Elizabeth T. Birzin, Karen L. MacNaul, Bruce A. Johnson, Gaochao Zhou and Chris J. Dickinson and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Diabetes.

In The Last Decade

Ralph Mosley

15 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ralph Mosley United States	12	698	218	183	172	163	15	1.2k
Jill M. McFadden United States	13	790 1.1×	213 1.0×	99 0.5×	206 1.2×	73 0.4×	17	1.3k
Kenneth Ellsworth United States	17	593 0.8×	189 0.9×	67 0.4×	140 0.8×	300 1.8×	25	1.2k
David G. Ahern United States	17	508 0.7×	153 0.7×	350 1.9×	207 1.2×	86 0.5×	53	1.2k
Don N. Harris United States	17	516 0.7×	272 1.2×	336 1.8×	175 1.0×	116 0.7×	43	1.2k
Rubén D. Garcia-Ordoñez United States	16	580 0.8×	146 0.7×	46 0.3×	80 0.5×	64 0.4×	25	1.2k
Bharat Shimpukade Denmark	12	559 0.8×	186 0.9×	23 0.1×	132 0.8×	218 1.3×	15	962
Chuan Ji United States	13	456 0.7×	94 0.4×	252 1.4×	112 0.7×	50 0.3×	23	872
Reeba K. Vikramadithyan United States	18	654 0.9×	237 1.1×	95 0.5×	141 0.8×	218 1.3×	27	1.2k
Toshihiko Fujiwara Japan	16	859 1.2×	337 1.5×	85 0.5×	92 0.5×	497 3.0×	21	1.6k
Dingbo Shi China	26	990 1.4×	122 0.6×	160 0.9×	63 0.4×	69 0.4×	46	1.7k

Countries citing papers authored by Ralph Mosley

Since Specialization

Citations

This map shows the geographic impact of Ralph Mosley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Mosley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Mosley more than expected).

Fields of papers citing papers by Ralph Mosley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Mosley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Mosley. The network helps show where Ralph Mosley may publish in the future.

Co-authorship network of co-authors of Ralph Mosley

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Mosley. A scholar is included among the top collaborators of Ralph Mosley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Mosley. Ralph Mosley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Evans, Joseph L., et al.. (2008). What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases. Trends in Pharmacological Sciences. 29(2). 72–78. 190 indexed citations

Janovick, Jo Ann, Akshay Patny, Ralph Mosley, et al.. (2008). Molecular Mechanism of Action of Pharmacoperone Rescue of Misrouted GPCR Mutants: The GnRH Receptor. Molecular Endocrinology. 23(2). 157–168. 44 indexed citations

Tan, Carina P., Yue Feng, George J. Eiermann, et al.. (2008). Selective Small-Molecule Agonists of G Protein–Coupled Receptor 40 Promote Glucose-Dependent Insulin Secretion and Reduce Blood Glucose in Mice. Diabetes. 57(8). 2211–2219. 133 indexed citations

Sun, Wanying, L. D. Cama, Elizabeth T. Birzin, et al.. (2006). 6H-Benzo[c]chromen-6-one derivatives as selective ERβ agonists. Bioorganic & Medicinal Chemistry Letters. 16(6). 1468–1472. 125 indexed citations

Deng, Qiaolin, Joseph Clemas, Gary Chrebet, et al.. (2006). Identification of Leu276 of the S1P1 Receptor and Phe263 of the S1P3 Receptor in Interaction with Receptor Specific Agonists by Molecular Modeling, Site-Directed Mutagenesis, and Affinity Studies. Molecular Pharmacology. 71(3). 724–735. 32 indexed citations

Feuston, Bradley P., Subhas J. Chakravorty, J. E. Conway, et al.. (2005). Web Enabling Technology for the Design, Enumeration, Optimization and Tracking of Compound Libraries. Current Topics in Medicinal Chemistry. 5(8). 773–783. 7 indexed citations

Deng, Qiaolin, Zhijian Lu, Kenneth Ellsworth, et al.. (2005). Modeling aided design of potent glycogen phosphorylase inhibitors. Journal of Molecular Graphics and Modelling. 23(5). 457–464. 7 indexed citations

Liu, Kun, Regina M. Black, John J. Acton, et al.. (2005). Selective PPARγ modulators with improved pharmacological profiles. Bioorganic & Medicinal Chemistry Letters. 15(10). 2437–2440. 56 indexed citations

Santini, Conrad, Gregory D. Berger, Ralph Mosley, et al.. (2003). Phenylacetic acid derivatives as hPPAR agonists. Bioorganic & Medicinal Chemistry Letters. 13(7). 1277–1280. 29 indexed citations

10.

Berger, Joel P., Ann Petro, Karen L. MacNaul, et al.. (2003). Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein γ Selective Modulator. Molecular Endocrinology. 17(4). 662–676. 271 indexed citations

11.

Nargund, Ravi P., Iyassu K. Sebhat, Khaled Barakat, et al.. (2001). Design and biological profile for selective agonists for the melanocortin subtype-4 receptor. 222. 151. 1 indexed citations

12.

Chen, Shiying, Bruce A. Johnson, Ying Li, et al.. (2000). Both Coactivator LXXLL Motif-dependent and -independent Interactions Are Required for Peroxisome Proliferator-activated Receptor γ (PPARγ) Function. Journal of Biological Chemistry. 275(6). 3733–3736. 42 indexed citations

13.

Yang, Yingkui, Tung M. Fong, Chris J. Dickinson, et al.. (2000). Molecular Determinants of Ligand Binding to the Human Melanocortin-4 Receptor. Biochemistry. 39(48). 14900–14911. 152 indexed citations

14.

Pasternak, Alexander, Yanping Pan, Philip E.J. Sanderson, et al.. (1999). Potent, orally bioavailable somatostatin agonists: Good absorption achieved by urea backbone cyclization. Bioorganic & Medicinal Chemistry Letters. 9(3). 491–496. 17 indexed citations

15.

Yang, Lihu, Liangqin Guo, Alexander Pasternak, et al.. (1998). Spiro[1H-indene-1,4‘-piperidine] Derivatives As Potent and Selective Non-Peptide Human Somatostatin Receptor Subtype 2 (sst₂) Agonists. Journal of Medicinal Chemistry. 41(13). 2175–2179. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact